Remove science diversity
article thumbnail

Innovations and Clinical Trial Diversity in Medical Aesthetics: Insights from Dr. Stephanie Manson Brown, VP & Head of Clinical Development at Allergan Aesthetics – Xtalks Life Science Podcast Ep. 134

XTalks

Manson Brown’s Clinical Development and Scientific Innovation team are responsible for global clinical trial development strategy for the Aesthetic Medicine portfolio, covering pharmaceuticals and device. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

Grand Rounds December 15, 2023: Diversifying Clinical Trials: A Path Forward (Roxana Mehran, MD, FACC, FAHA, MSCAI, FESC)

Rethinking Clinical Trials

Yet enrollment of ethnic minorities in NIH clinical trials and for trials studying approved devices and drugs remains low. There are several strategies that will help increase diversity in CVD trials. Many high school and college students are moving away from the sciences. Trainees don’t see a way forward.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Insights from Industry Experts: Examining the Patient Experience in Clinical Trial Design

Worldwide Clinical Trials

With the necessary prioritization of various factors when designing your clinical trial, the patient experience can be overlooked or improperly addressed in study design. However, she urges sponsors to try to understand the patient community first before launching a clinical trial so they can understand the patients’ needs and wants.

article thumbnail

Pharma Mirror Q&A with Jane Myles, Vice President of Clinical Trial Innovation at Curebase

Pharma Mirror

The White House Office of Science & Technology Policy (OSTP) convened a listening session January 11. Jane Myles, vice president of clinical trial innovation at Curebase, was among the distinguished panelists.

article thumbnail

Clinical Trials For All Campaign: Converging Trials and Healthcare

XTalks

Recruiting participants is perhaps the most challenging aspect of any clinical trial, regardless of the therapeutic area. Yet this one piece is also the most vital, with a trial’s ability to enroll and retain participants being a key predictor of a study’s future success. What is Clinical Trials For All?

article thumbnail

Improving Black Participation in Clinical Trials: Bridging the Gap

XTalks

Black participation in clinical trials, and the underrepresentation of minority groups in general in trials, remains low. This lack of diversity can lead to skewed results that may not accurately reflect the efficacy of medical interventions across all populations.

article thumbnail

3 Key Takeaways from Psychedelic Science 2023

Worldwide Clinical Trials

I was fortunate to have the opportunity to attend Psychedelic Science 2023 during the third week of June in Denver, Colorado. The event provided a unique opportunity to interact with a large and diverse group of fellow stakeholders, expanding my perspective on the impact of psychedelic clinical trials.